171 related articles for article (PubMed ID: 36316365)
21. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
22. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
23. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression.
Ma X; Qi S; Duan Z; Liao H; Yang B; Wang W; Tan J; Li Q; Xia X
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28963737
[TBL] [Abstract][Full Text] [Related]
25. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.
Lin C; Huang F; Li QZ; Zhang YJ
Int J Clin Exp Pathol; 2014; 7(10):6543-50. PubMed ID: 25400732
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
[TBL] [Abstract][Full Text] [Related]
27. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.
Matsushima K; Isomoto H; Yamaguchi N; Inoue N; Machida H; Nakayama T; Hayashi T; Kunizaki M; Hidaka S; Nagayasu T; Nakashima M; Ujifuku K; Mitsutake N; Ohtsuru A; Yamashita S; Korpal M; Kang Y; Gregory PA; Goodall GJ; Kohno S; Nakao K
J Transl Med; 2011 Mar; 9():30. PubMed ID: 21426561
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
[TBL] [Abstract][Full Text] [Related]
29. Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma.
Lee YC; Lin CH; Chang WL; Lin WD; Pan JK; Wang WJ; Su BC; Chung HH; Tsai CH; Lin FC; Wang WC; Lu PJ
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457185
[TBL] [Abstract][Full Text] [Related]
30. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
31. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
32. Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.
Karami Madani G; Rad A; Molavi M; Ardalan Khales S; Abbaszadegan MR; Forghanifard MM
J Gastrointest Cancer; 2018 Dec; 49(4):437-441. PubMed ID: 28681114
[TBL] [Abstract][Full Text] [Related]
33. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
Chen M; Xia Z; Chen C; Hu W; Yuan Y
Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
[TBL] [Abstract][Full Text] [Related]
34. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.
Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH
Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643
[TBL] [Abstract][Full Text] [Related]
35. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
[TBL] [Abstract][Full Text] [Related]
36. MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone.
Zhang Y; Duan Y; Wu C; Peng W; Chen W; Wang L; Deng Z
Growth Factors; 2022 Nov; 40(5-6):175-185. PubMed ID: 36067091
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429.
Sun Y; Hou Z; Luo B; Li C; Liu J; Liu J; Tang J; Yao G
Bioengineered; 2021 Dec; 12(1):4159-4173. PubMed ID: 34288815
[TBL] [Abstract][Full Text] [Related]
38. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma.
Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
Biochimie; 2019 Aug; 163():84-93. PubMed ID: 31158427
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2.
Sun XB; Chen YW; Yao QS; Chen XH; He M; Chen CB; Yang Y; Gong XX; Huang L
Technol Cancer Res Treat; 2021; 20():1533033821989817. PubMed ID: 33550923
[TBL] [Abstract][Full Text] [Related]
40. [Serum level of lncRNA TUSC7 in patients with esophageal squamous cell carcinoma and its role in promoting tumor cell migration and invasion].
Zhao K; Guo Y; Huo Z; Ma G; Zhang G; Xing Y; Xu Q
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):661-669. PubMed ID: 32897196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
